Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2Sarcoma 1Head & Neck 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Thyroid Neoplasms 5Breast Neoplasms 3Thyroid Carcinoma, Anaplastic 2Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Head and Neck Neoplasms 2Thyroid Cancer, Papillary 1Salivary Gland Neoplasms 1Recurrent Lymphoepithelioma of the Nasopharynx 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Melanoma 1Lung Neoplasms 1Liver Neoplasms 1Kidney Neoplasms 1Gastrointestinal Neoplasms 1Endometrial Neoplasms 1Colonic Neoplasms 1Cholangiocarcinoma 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Medullary 1Adenocarcinoma, Follicular 1

Interventions

Peripheral Blood Stem Cell Transplantation 3Filgrastim 3Cisplatin 3selpercatinib 2pembrolizumab 2Etoposide 2Carboplatin 2regorafenib 1pentetreotide 1pazopanib 1etoposide phosphate 1epothilone B 1entrectinib 1durvalumab 1carbon-11 methionine 1cabozantinib 1aflibercept 1Thiotepa 1Temozolomide 1Tamoxifen 1Surveys and Questionnaires 1Radiotherapy 1Quality of Life 1Patient Reported Outcome Measures 1Paclitaxel 1Nivolumab 1NEO212 1Molecular Diagnostic Techniques 1Methionine 1MLN 8237 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Central Nervous System Neoplasms × pazopanib × Head & Neck × Clear all
NCT01639911 2019-07-22

Phase I Study of MLN8237 and Pazopanib in Patients With Solid Tumors

University of Illinois at Chicago

Phase 1 Completed
28 enrolled
BreastCNSDermatologicGastrointestinalHead & Neck

Breast Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Melanoma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡